Key result
BP dipping linked to ~32% lower LVH risk vs non-dipping in untreated white coat hypertension.
Why the study?
White coat hypertension remains a management grey zone for clinicians, and its link to target organ damage is still understudied.
Does non-dipping blood pressure status or nocturnal hypertension increase target organ damage in adults with untreated white coat hypertension?
Cross-Sectional (n=547)
No
Does non-dipping blood pressure status or nocturnal hypertension increase target organ damage in adults with untreated white coat hypertension?
Effect estimate: OR 0.68 (95% CI 0.48-0.97)
p-value: p=0.032
In adults with untreated white coat hypertension, a non-dipping blood pressure pattern is significantly associated with an increased risk of left ventricular hypertrophy and reduced renal function.
Supports ABPM phenotyping of dipping status in WCH but should not yet change practice; leaves open benefit of targeted intervention in prospective trials.[[1]](https://www.nature.com/articles/s41371-026-01152-7)[[1]](https://www.nature.
White coat hypertension (WCH) is still a grey zone regarding its management by clinicians, while its link to target organ damage (TOD) is still understudied. The aim of this study was to explore the impact of non-dipping status and nocturnal hypertension on TOD in untreated WCH subjects. A cross-sectional study of 547 individuals with WCH was conducted at a single institution. Patients underwent a thorough clinical examination, including medical history, office BP measurements, echocardiography, carotid artery ultrasonography, serum creatinine level measurements, and ambulatory blood pressure monitoring. Left ventricular hypertrophy (LVH), intima-media thickness of the common carotid artery (IMT-CCA) and estimated Glomerular Filtration Rate (eGFR) were used as TOD indices. The patients were divided into dippers and non-dippers, as well as nocturnal hypertensives and normotensives. Among WCH patients, 49.9% were non-dippers and 33.6% had nocturnal hypertension. Dippers had a significantly lower risk of left ventricular hypertrophy (OR: 0.68, 95%CI: 0.48 – 0.97) and higher mean expected eGFR values (b = 7.03, 95%CI: 3.12 – 10.94) than non-dippers. For IMT-CCA, office systolic and diastolic BP were the only significant predictors (b = 0.02, 95%CI: 0.00 – 0.03 and b = -0.03, 95%CI: -0.05 – -0.01). Office systolic BP was also significantly associated with eGFR (b = -1.68, 95%CI: -2.84 – -0.52). The results of this study indicate that non-dipping status is a significant risk factor for LVH and renal function in WCH subjects. Therefore, nighttime BP patterns, especially non-dipping, should be examined in patients with WCH.
No takes yet. Share an insight, caveat, or question.
Papasotiriou et al. (2026) conducted a cross-sectional in White coat hypertension (n=547). Blood pressure dipping vs. Non-dipping was evaluated on Left ventricular hypertrophy (OR 0.68, 95% CI 0.48-0.97, p=0.032). Blood pressure dipping was associated with a 32% lower risk of left ventricular hypertrophy compared to non-dipping in untreated adults with white coat hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: